Observational and prospective study of the ultrasound response to methotrexate in rheumatoid arthritis patients who started methotrexate
* Rheumatoid arthritis patients with active disease who start subcutaneous methotrexate by their rheumatologist prescription methotrexate will be included. * Patients will participate in a prospective and observational study in which the response to methotrexate will be assessed by ultrasound (US) of joints and tendons. * The main objective of the study is the change in B mode and Doppler mode US after 24 weeks of methotrexate treatment.
Study Type
OBSERVATIONAL
Enrollment
50
standard of care treatment with methotrexate
Hospital General Universitario Gregorio Marañón
Madrid, Spain
RECRUITINGUltrasound response
Change in B mode and Doppler mode synovitis and tenosynovitis
Time frame: Basal and at 6 months
Clinical response
Change in disease activity measured by DAS28, CDAI and SDAI
Time frame: Basal and 6 months
Functional response
Change in functional status measured by HAQ
Time frame: Basal and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.